Keros Therapeutics Correlations

KROS Stock  USD 11.22  0.22  1.92%   
The current 90-days correlation between Keros Therapeutics and Ideaya Biosciences is 0.27 (i.e., Modest diversification). The correlation of Keros Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Keros Therapeutics Correlation With Market

Good diversification

The correlation between Keros Therapeutics and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Keros Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Keros Stock please use our How to Invest in Keros Therapeutics guide.

Moving together with Keros Stock

  0.67CDIOW Cardio DiagnosticsPairCorr
  0.71ELVN Enliven TherapeuticsPairCorr
  0.61SCLX Scilex HoldingPairCorr
  0.63ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.9CDIO Cardio DiagnosticsPairCorr
  0.94CRNX Crinetics PharmaceuticalsPairCorr
  0.64MRK Merck CompanyPairCorr

Moving against Keros Stock

  0.88GE GE AerospacePairCorr
  0.86PLX Protalix BiotherapeuticsPairCorr
  0.73WM Waste ManagementPairCorr
  0.64LUCD Lucid DiagnosticsPairCorr
  0.59MLSS Milestone Scientific Earnings Call This WeekPairCorr
  0.89MMM 3M CompanyPairCorr
  0.76CVX Chevron CorpPairCorr
  0.74CSCO Cisco SystemsPairCorr
  0.65IBM International BusinessPairCorr
  0.63JNJ Johnson JohnsonPairCorr
  0.62T ATT Inc Earnings Call TomorrowPairCorr
  0.6JPM JPMorgan ChasePairCorr
  0.55XOM Exxon Mobil CorpPairCorr
  0.41INTC IntelPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
JANXIDYA
AVTEJANX
AVTEIDYA
SNDXFENC
EWTXJANX
EWTXIDYA
  
High negative correlations   
JANXMGTX
MGTXIDYA
FENCJANX
EWTXMGTX
FENCIDYA
JANXANAB

Risk-Adjusted Indicators

There is a big difference between Keros Stock performing well and Keros Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Keros Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
IDYA  2.30 (0.42) 0.00 (1.17) 0.00 
 4.11 
 12.18 
ANAB  4.32  0.41  0.08  0.23  4.43 
 9.84 
 43.41 
MGTX  3.13  0.40  0.13 (1.29) 3.41 
 5.56 
 34.28 
FIXX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
JANX  2.83 (0.91) 0.00 (0.72) 0.00 
 8.08 
 20.17 
FENC  2.06  0.26  0.08  0.14  2.93 
 4.75 
 16.33 
EWTX  2.92 (0.07) 0.00 (0.12) 0.00 
 5.32 
 26.44 
HRMY  1.98  0.23  0.07  0.17  2.96 
 4.36 
 17.63 
AVTE  1.29  0.02  0.04  0.00  1.52 
 2.07 
 10.45 
SNDX  2.39  0.07  0.03  0.02  2.91 
 6.51 
 15.51 

Keros Therapeutics Corporate Management

Robin WagnerSenior ResourcesProfile
Simon MBBSChief OfficerProfile
Keith MBAChief OfficerProfile
Christopher MScChief OfficerProfile
John MBASenior ManagementProfile
Jennifer LacheyChief OfficerProfile
Jasbir SeehraCEO and PresidentProfile